Imperva stock: buy or sell?
January 9th, 2019
Imperva, Inc. engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide.
Should I buy Imperva stock?Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. Having a trading strategy helps to make decisions easier, quicker and with less hesitations. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
None of our preferred buy setups matches with Imperva stock situation right now, hence this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Imperva stock a buy?
Financial institutions and banks post stock ratings everyday.Unfortunately, we couldn't detect any rating for IMPV stock for the last 30 days.
Imperva stock analysis
Imperva ended at $55.74 and stayed constant a tight 0.02%.
Shares of Imperva ended at $55.74 and stayed steady a tight 0.02%. When IMPV stock price broke up the SMA200d line, it gained $12.68 (29.45%). , SMA50d and SMA100d crossed up triggering a rise of 0.07%.
Imperva shares stayed steady 0.11% early January, ending at $55.74. For 4 weeks in a row, price climbed and marked a profit of 0.49%.
Far behind is the all-time high Imperva recorded by mid July 2018 but price is just -3.31% below that top. Since price and SMA40w lines crossed up early October, IMPV climbed $11.86 (27.03%). Since late October 2018 when SMA10w and SMA20w crossed up, IMPV price gained $0.41 per share (0.74%).
Imperva stock price history
Imperva stock went public on September 27th, 2017 with a price of $43.501. Since then, IMPV stock grew a 28.10%, with a yearly average of 14.10%. If you had invested right after IMPV's IPO a $1,000 in Imperva stock in 2017, it would worth $281.00 today.
1: Adjusted price after possible price splits or reverse-splits.
Imperva stock historical price chart
IMPV stock reached all-time highs with a price of $57.65.
Imperva stock price targetHow much a stock will be priced tomorrow or next week is quite unpredictable However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we have not detected any price prediction for Imperva stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per Share, when Imperva posted its last earnings report, it remained stable a neutral 0.70%. Unfortunately, reported EPS is not yet available in our database. Imperva is reporting earnings for 2018-Q4 , with an expected Earnings per Share (EPS) of $0.14.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2016, last anual sales report draw an astounding increase of 21.65% to $321.72 million USD. Likewise, its profit margin (compared to revenues) skyrocketed to 7.11%, that is $22.87 million. Imperva fiscal year ends in December, and to compare its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, Imperva TTM sales up to September 2018 were $351.76 and income $-28.14 M USD. If we compare this TTM figures with the last reported annuality, we can review Imperva business evolution since December 2017: Annual turnover up to September, compared to lastest yearly report, soared a great 9.34%. Regarding profit margin, Imperva plunged -15.11% to 7.11%
|2013||$138 M||-||$-25.18 M-18.3%||-|
|2014||$164 M||19.05%||$-58.96 M-36.0%||134.17%|
|2015||$234 M||42.86%||$-48.88 M-20.9%||-17.10%|
|2016||$264 M||12.87%||$-70.28 M-26.6%||43.77%|
|2017||$322 M||21.65%||$23 M7.1%||-132.54%|
|TTM||$352 M||9.34%||$-28.14 M-8.0%||-223.03%|
Quarterly financial resultsImperva reported $91.63 M in revenues for 2018-Q3, a 8.06% improvement compared to previous quarter. Reported quarter income marked $1.06 million with a profit margin of 1.15%. Profit margin boosted a 28.35% compared to previous quarter when profit margin was -27.19%. When comparing sales to same quarter last year, Imperva sales marked a superb gain and rose a 9.23%. Looking back to recent quarterly results, Imperva posted 2 positive quarters in a row.
|2016-Q4||$78 M||-||$-9.82 M-12.5%||-|
|2017-Q1||$72 M||-7.77%||$23.08 M31.9%||-335.03%|
|2017-Q2||$74 M||2.95%||$-3.49 M-4.7%||-115.12%|
|2017-Q3||$84 M||12.69%||$-0.37 M-0.4%||-89.40%|
|2017-Q4||$91 M||8.57%||$3.65 M4.0%||-1,085.41%|
|2018-Q1||$84 M||-7.51%||$-9.78 M-11.6%||-368.27%|
|2018-Q2||$85 M||0.66%||$-23.06 M-27.2%||135.75%|
|2018-Q3||$92 M||8.06%||$1.06 M1.2%||-104.59%|
Imperva ownershipWhen you are planning to invest in shares of a company, it's always worth to check its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Imperva, of all outstanding shares are owned by its staff.
The following table compares ownership indicators for other stocks related to Imperva:
|Market cap||$0.0 M|
|Total shares||0.0 M|
|Float shares||0.0 M|
|- Institutional holdings (%)||0.0%|
|- Insider holdings (%)||0.0%|
|Shares in short selling||0.0%|
|Wednesday, January 9th, 2019|
|Day range||$55.71 - $55.75|
|Average true range||$0.10|
|50d mov avg||$55.65|
|100d mov avg||$51.94|
|200d mov avg||$50.21|
Imperva performanceStocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. We picked as the bechmarking frame for Imperva stock.